Equine inflammatory disease is accompanied by a neutrophil activation resulting in the release of granulocytic enzyme myeloperoxidase (MPO). To measure MPO in horse plasma as marker of neutrophil activation, the authors purified equine neutrophil MPO and developed a specific enzyme immunoassay using 2 specific polyclonal antibodies obtained from rabbit (primary antibody) and guinea pig (secondary antibody). The sandwich complex ''primary antibody-MPO-secondary antibody'' was detected using a goat anti-guinea pig immunoglobulin antibody conjugated to alkaline phosphatase. The enzyme-linked immunosorbent assay (ELISA) showed good precision and accuracy, with intra-and interassay coefficients of variation below 10% for MPO concentrations ranging from 0.78 to 50 ng/ml. A stable plasma MPO value, unaffected by time elapsed between blood collection and centrifugation, was obtained with plasma from EDTA anticoagulated blood. The mean MPO value measured in 38 healthy horses was 181.80 Ϯ 64.74 ng/ml. In 20 horses suffering from obstruction of the large or small intestine, MPO concentrations measured at the time of arrival at the intensive care unit were significantly higher than mean normal value, ranging from 477.88 to 2,748.13 ng/ml. Work is in progress to apply this MPO ELISA technique to other biological fluids and other equine diseases.
Introduction
Myeloperoxidase (MPO) is a specific heme enzyme of the azurophilic granules of the polymorphonuclear leukocytes (neutrophils). 3 Myeloperoxidase participates in pathogen destruction within the phagocytic vacuole of neutrophils. It is specifically responsible for the production of a potent oxidant agent, hypochlorous acid synthetized from chloride anion (Cl Ϫ ) and hydrogen peroxide. 10, 18 Hypochlorous acid is able to destroy the bacterial polysaccharide capsules that are resistant to the action of proteinases. 10, 37 During their fight against microorganisms, dying neutrophils release MPO into the surrounding milieu. When neutrophil activation becomes excessive and uncontrolled (as in acute inflammatory disease), high amounts of MPO is released and its concentration increases in the biological milieu (e.g., plasma, tissues, broncho-and alveolar fluids), leading to an increased risk of cytotoxicity caused by in situ production of oxidants when MPO From the Department of General Anesthesia and Surgical Pathology of Large Animals, Institut Vétérinaire B 41, Université de Liège, Sart Tilman, BE-4000 Liège, Belgium (Franck, Grulke, Peters, Serteyn), Oxygen Center, Research and Development, Institut de Chimie B 6a, Université-Sart Tilman, BE-4000 Liège, Belgium (Franck, Deby-Dupont, Deby, Serteyn), and the European Horse Center of Mont-le-Soie, 6698 Grand-Halleux, Belgium (Duvivier). 1 Corresponding Author: T. Franck, Anesthésiologie et Pathologie Chirurgicale des Grands Animaux, Institut Vétérinaire, B 41, Université de Liège, Sart Tilman, BE-4000 Liège, Belgium.
The ELISA technique described in this report for equine MPO measurement is protected by patent (04447027. 6 ) and now distributed by Biocode Hycel, Liège, Belgium. binds to or is captured by neighboring cells. 23, 24, 31 In humans, an increase in MPO concentration in plasma or other body fluids is now considered as a marker of neutrophil activation in several disease conditions, including ischemia-reperfusion injury, respiratory distress syndrome, glomerulonephritis, arthritis, peptic ulcer formation, gastric cancer, and cardiovascular disease. 4, 20, 21, 37 In veterinary equine medicine, neutrophil activation intervenes in diseases that are associated with an inflammatory response such as laminitis, intestinal strangulation, or recurrent airway obstructions. 9, 15, 36 Currently, measurement of neutrophil MPO release in horses to detect neutrophil activation is only performed by enzymatic methods. These techniques are difficult and cumbersome and are not applicable to complex biological milieu such as blood or plasma because of the presence of components with peroxidase activity (e.g., hemoglobin), 16, 27 proteins (e.g., albumin, lipoproteins, ceruloplasmin), 5, 34 and reducing agents (e.g., ascorbic acid) 13 that interfere with the enzymatic measurement. No technique has been developed for the measurement of the total concentration of equine MPO in biological fluids, except for a radioimmunological assay (RIA) that was previously developed by the authors. 11 Using this technique, it was observed that a significantly higher plasma level of MPO in horses operated for strangulation obstruction of the large intestine than in horses suffering from a nonstrangulated displacement of the large intestine. 15 However, the RIA technique is difficult to apply as a routine test because it requires radiolabeling, specialized equipment, and a permit to use of radioactive materials. McConnico et al. 26 detected MPO activity using a histological method and found that tissue inflammation scores in horses were positively correlated with the tissue activity of this enzyme. On the basis of the results obtained by RIA and histological techniques, it is obvious that an easier method for MPO measurement might be useful in quantifying the severity and evolution of intestinal inflammation in horses. In this study, the development and preliminary evaluation of a sandwich-type enzyme-linked immunosorbent assay (ELISA) for equine MPO for routine use in plasma has been described.
Materials and methods
Purification of equine MPO. Myeloperoxidase was extracted from equine polymorphonuclear leukocytes isolated from whole blood by sedimentation on Ficoll-Paque a density gradient. The purification was performed, following a modification of a previously described technique. 22 In brief, packed neutrophils were homogenized in sodium acetate buffer (0.2 M Na-acetate; 1 M NaCl; pH 4.7) containing 1% cetyltrimethylammonium bromide. b The supernatant was collected by centrifugation and dialyzed. Dialysis allowed precipitation of elastase and cathepsin G, whereas MPO was recovered in the supernatant and subsequently loaded on ion exchange Hiload SP Sepharose column a (1.6 ϫ 15 cm) equilibrated with 25 mM Na-acetate, 0.2 M NaCl, pH 4.7. The presence of proteins was monitored in the column effluent by UV absorbance at 280 nm. Anionic proteins were eluted in an initial peak, and after the absorbance returned to baseline, an NaCl gradient was applied in 3 steps to release cationic proteins: 0.2-0.38 M in 10 ml followed by 0.38-0.6 M in 120 ml and 0.6-1 M in 60 ml. During the second gradient step, 2 main peaks of proteins without MPO activities were observed. Myeloperoxidase was eluted during the third gradient step at 0.75 M NaCl. The fractions containing the highest MPO activity determined by an enzymatic assay using o-dianisidine as substrate 38 were pooled and loaded on Hiload Superdex 200 gel filtration column a (1.6 ϫ 60 cm) eluted with 25 mM Na-acetate, 0.2 M NaCl, pH 4.7. For the 2 chromatographic steps, flow rate was maintained at 2 ml/ min and fractions of 4 ml were collected. The purity of MPO was assessed by enzymatic assays (o-dianisine technique) and by electrophoresis on polyacrylamide gel.
Electrophoresis. After the last chromatographic step, the MPO-rich fractions were pooled and concentrated in Naacetate buffer (25 mM, pH 4.7). The purity of MPO was assayed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (ExcelGel SDS, gradient 8-18). a Nonreduced and reduced (by 5 mM dithiothreitol c or DTT) samples were loaded onto the gel. After migration, gels were fixed with a mixture of acetic acid (10%), ethanol (50%), and water (40%), and stained for protein with Coomassie brilliant blue. b Myeloperoxidase activity was determined in situ directly after migration by covering the gel with a solution of o-dianisidine (50 mM; pH 5.5) containing 150 M H 2 O 2 .
Detection of glycoprotein by periodic acid-Schiff staining was performed according to the method of Doerner and White. 12 Immunization of animals and purification of polyclonal antibodies. Animal housing, immunization, and rabbit and guinea pig anti-equine MPO antiserum collections were performed at the Laboratory of Hormonology (Centre d'Economie Rurale, Marloie, Belgium). Antisera were raised in 2 rabbits and 1 guinea pig by intradermal injection (1 ml volume per injection) with 100 g of purified equine MPO dissolved in 500 l of 25 mM Na-acetate, 0.2 M NaCl, at pH 5.5, emulsified with 1 equivalent of complete Freund adjuvant. Booster injections were given at days 14, 28, 42, and 56 with 50 g of emulsified MPO. Blood samples were collected at the marginal vein of the ear, 10 days after each booster injection. Twenty-four days after the last booster, the animals were exsanguinated by heart puncture under general anesthesia. Purification of immunoglobulins from antisera was made by affinity chromatography on Protein A sepharose column. a Reactivity of the 2 antibodies against equine MPO was qualitatively tested by immunodiffusion (Ouchterlony technique).
Sandwich ELISA for equine MPO. Four buffers were prepared for this technique. The coating buffer was phosphatebuffered saline: 20 mM phosphate buffer (pH 7.4), 137 mM NaCl, and 2.7 mM KCl. The blocking buffer was obtained by addition of 5 g/liter bovine serum albumin to the coating buffer. The diluting buffer was the blocking buffer with 0.1% Tween 20. The washing buffer was a solution of 154 mM NaCl with 0.1% Tween 20. Microplate wells (Cliniplate EB) d were coated (overnight, at 4ЊC) with a saturating amount of rabbit anti-MPO antibody (3 g/ml) diluted in the coating buffer. After 3 washing steps, blocking buffer was added and the plates were incubated for 150 min at room temperature (Ϯ20ЊC). After 3 washes, equine MPO standard or test antigen was incubated overnight with the primary antibody (rabbit anti-MPO immunoglobulin [Ig]G) at 4ЊC. The plates were washed 3 times and the immobilized antibody-antigen complexes were incubated (2 hr, 37ЊC) with an excess (5 g/ml) of the secondary antibody (guinea pig anti-MPO IgG). After washing, a third antibody produced in goat against guinea pig IgG and labeled with alkaline phosphatase b was added to recognize the ''sandwich'' complex (''primary antibody-MPO-secondary antibody''). After washing, phosphatase activity was detected by incubation (30 min, 37ЊC, in the dark) with the substrate paranitrophenyl phosphate b (2.7 mM) in DEA buffer (9.7% diethanolamine, b 0.02% NaN 3 , 0.01% MgCl 2 , pH 9.8). The reaction was stopped with 2.5 M NaOH, and the absorbance (405 nm) was read with the Multiscan Ascent plate reader. d All the reagents were added into the wells in a 100 l volume, except for the washing buffer (300 l) and the blocking and substrate solutions (200 l). Control (blank) and dilutions of the samples were done with the dilution buffer. The absorbance value was directly proportional to the quantity of the sandwich complex and, therefore, to the concentration of MPO in the sample.
Validation of the ELISA. The cross-reactivities of the anti-MPO antibodies with equine plasma proteins and with proteins from cellular components of blood were measured as described previously by Deby-Dupont et al. 11 The detection limit was defined as the lowest MPO concentration that was statistically different (mean value Ϯ SD) from the value obtained with buffer alone. The standard curve of the ELISA was calculated and plotted point to point using the Ascent software for the Multiscan Ascent plate reader. d The precision and reproducibility were estimated by the coefficients of variation (CV) within or between assays calculated for several measurements from the sample. The accuracy was assessed by investigating the parallelism between the standard curve and the curves obtained from successive dilutions of a given plasma sample and by estimating the detection of known amounts of MPO (10 and 20 ng/ml) spiked into equine plasma samples.
Blood sampling technique. Blood samples were drawn from the jugular vein into plain tubes e or tubes containing EDTA (1.6 mg/ml blood), e heparin (15 IU/ml blood), e or citrate (0.5 ml Na-citrate solution 106 mM). e Blood in plain tubes was allowed to clot (4 hr) at room temperature (Ϯ20ЊC). The blood samples were centrifuged for 10 min at room temperature at 1,000 ϫ g. The plasma and serum were kept frozen in small aliquots at Ϫ20ЊC. Immediately before performing the ELISA, samples were thawed and diluted with the dilution buffer. To study the effect of the delay between blood sampling and centrifugation, blood was taken from 5 healthy horses and centrifuged directly or at several intervals (20 min, 2 hr, and 4 hr) after sampling.
Mean normal values of MPO in blood. Blood samples from 37 healthy horses were drawn into EDTA tubes. Plasma was collected by centrifugation and frozen at Ϫ20ЊC until assayed. A horse was considered as clinically healthy if no clinical signs of acute disease and no change in health status were observed during the sampling period.
Effect of intestinal diseases on blood MPO. Blood samples were obtained from 20 full-bred horses with obstructive intestinal disease of large (n ϭ 10) or small intestine (n ϭ 10). The blood was collected into EDTA tubes (with immediate centrifugation) at the arrival of the horse at the veterinary intensive care unit.
Results

Purification of equine MPO
After the last purification step, 1.3 mg of equine neutrophil MPO from 15 liters of blood was obtained. The pure enzyme had a specific activity of 144.3 U/ mg. The enzymatic activity was pH dependent (optimal pH: 5.5). Electrophoresis of the equine MPO in nonreducing conditions showed 3 bands: 2 with molecular masses near 120 kD (native enzyme) and 1 at 86 kD (precursor) (Fig. 1A) . The peroxidase activity (defined as the staining of the gel with o-dianisidine in the presence of H 2 O 2 ) showed activity located on the two 120-kD bands under nonreducing conditions ( Fig. 1A o-dianisidine) . Schiff reagent staining, which indicated glycosylation, was positive for the two 120and 86-kD bands. A second weakly stained band was visible near 120 kD (Fig. 1A Schiff) .
The electrophoresis of MPO treated with DTT to break internal disulfide bridges before loading onto the gel revealed the subunit structure of the enzyme: persistence of the band at 86 kD, disappearance of the band at 120 kD, and 3 new bands at 76, 64, and 16 kD, corresponding, respectively, to the hemienzyme and the heavy and the light subunits of the enzyme (Fig. 1 AR) . A weakly stained band appeared at a molecular mass of 44 kD that could result from an intramolecular disulfide bridge break or a heavy subunit without the prosthetic group.
Assay optimization
After a first dose and 4 booster injections of purified MPO, the rabbits and the guinea pig produced antisera against equine MPO, as qualitatively determined by immunodiffusion (Ouchterlony technique). These antisera did not cross-react with equine albumin or other equine plasma proteins. In this study, the effect of several concentrations of the coating antibody (rabbit anti-MPO antibody): 1,200, 600, 300, 150, 75 ng/well was evaluated. On the basis of the detection limit and the slope of the standard curve, the authors chose 600 ng/ well (or 3 g/ml) as the optimal coating antibody concentration. After washing, the coated plates could be stored at 4ЊC under dry conditions for up to 4 weeks. For the ELISA test, the best conditions for MPO binding to the coated antibodies were obtained with an overnight incubation time (18 hours) at 4ЊC, especially for the highest MPO concentrations (Table 1) . When the rapidity of the test was made a priority factor, a short incubation time (2 hours) either at 25ЊC or 37ЊC could be used with good reproducibility. For further studies, the authors selected an overnight incubation (18-20 hours) at 4ЊC as the optimal MPO binding coating condition. The concentration of the secondary antibody (guinea pig anti-MPO antibody) was chosen to allow an optimal reaction with the goat anti-guinea pig IgG antibody enzyme conjugated according to the manufacturer's instructions.
Calibration curve and detection limit
The standard curve was obtained by plotting the absorbance values at 405 nm as a function of standard MPO concentrations. The classical standard curve reached a plateau for the highest MPO concentrations ( Fig. 2A) . When MPO concentrations were expressed in the logarithmic form, a linear curve was obtained for MPO values from 3 to 25 ng/ml (Fig. 2B) . The linear regression obtained from the standard curve after polynomial transformation showed a good correlation coefficient (0.99) with a deviation between the 2 curves at the extreme concentration values. To minimize interpolation errors, it was decided to use the curve with logarithmic transformation of MPO concentrations for MPO measurement in biological sam- ples. Table 2 shows the corrected absorbance values of a typical reference MPO curve. Corrected absorbance values were obtained by subtracting the blank absorbance value (nonspecific binding signal of the zero MPO concentration assay). The intraassay CV did not exceed 8% ( Table 2 ). Myeloperoxidase concentrations between 3.125 and 25 ng/ml, corresponding to the linear part of the curve, showed absorbance values with a CV lower than 5%. The detection limit of the test was 0.50 ng MPO/ml.
Measurement of MPO in equine blood
Dilution effect and recovery. The accuracy of the ELISA for measuring MPO in plasma was confirmed by the parallelism between the standard curve and the dilution curves of 3 plasma samples obtained from blood drawn on different anticoagulants ( Fig. 2A ). Known amounts of MPO (10 or 20 ng/ml) spiked into 6 plasma samples were analyzed using ELISA. The mean analytical recovery of MPO was 90.87 Ϯ 7.89% ( Table 3) .
Effect of delay in blood centrifugation. After immediate centrifugation of the blood, the mean MPO concentrations measured in plasma drawn on EDTA (178.09 Ϯ 91.07 ng/ ml) and citrate (151.82 Ϯ 97.07 ng/ml) were similar and did not significantly change even when the blood was centrifuged after a delay of 4 hours (Fig. 3) . A high mean MPO value was found in heparinized blood, and the value increased as centrifugation was delayed (Fig. 3) . A high mean value was found in serum ( Fig. 3) . On the basis of these results, it was decided to use EDTA-anticoagulated blood for all the other studies.
Quantitative analysis of MPO in equine plasma
The mean normal value obtained from 38 EDTAblood samples was 181.80 Ϯ 64.74 ng/ml (range: 113.2-352.7 ng/ml). On the basis of this data, a blood MPO value above the mean of the upper normal limit plus 3 SD (i.e., 376 ng/ml) was considered as an abnormal value (risk of error: P Ͻ 0.01). High values of MPO (above the upper limit of the normal value) were measured in the blood of 20 horses suffering from intestinal diseases. The mean MPO values were 1,430.88 Ϯ 491.41 ng/ml (n ϭ 10; range: 567.12-2,219.14 ng/ ml) and 1,287.56 Ϯ 793.09 ng/ml (n ϭ 10; range: 477.88-2,748.13 ng/ml) for horses suffering from strangulated obstruction of the large and small intestine, respectively. Individual values are presented in Fig. 4 . Statistical cutoff value was identified between the healthy (n ϭ 38) and the pathological (n ϭ 20) horses using receiver operating characteristic (ROC) curve analysis. f The optimal cutoff point to distinguish between ''health'' and ''pathology'' was 352.7 ng/ml of MPO content (sensitivity 100%, specificity 97%). The area under the ROC curve was 1.0 (95% confidence interval 0.938-1.000).
Intra-and interassay variations
Intraassay precision was estimated by replicating plasma sample measurements in the same run. The CV obtained for 4 different plasma samples with MPO concentrations ranging between 100 and 1,500 ng/ml did not exceed 10%. The mean CV value obtained for all the samples of this test (n ϭ 17) was 5.51 Ϯ 1.92% ( Table 4 ). The CVs were also calculated for 30 samples tested in triplicate in 1 run ( Fig. 5 ): only 4 samples showed a CV between 8% and 12%. The mean CV value obtained for this study was 5.83 Ϯ 3.17%.
Interassay precision was estimated by triplicate assay of 4 plasma samples repeated in different runs over a period of 5 days. The CVs for MPO concentrations ranging between 100 and 1,700 ng/ml did not exceed 10% ( Table 4 ). The mean CV value obtained for this test was 7.15 Ϯ 1.33%.
Discussion
By following the technique of Mathy-Hartert et al., 22 the equine neutrophil MPO with a satisfactory A 430 / A 280 absorbance ratio (Ͼ0.5) and a good specific activity (144.3 U/mg) was obtained. By electrophoresis, 2 electrophoretic bands with molecular masses near 120 kD were found. By comparison with other data for human 32 and bovine 6 MPO emphasizing the heterogeneity of the enzyme, these bands were identified as 2 isoforms of the mature tetrameric enzyme. These two 120-kD bands were enzymatically active, and the most active band showed a less intense Coomassie and Schiff staining, suggesting a dependence of equine MPO activity on the level of glycosylation. Iwamoto et al. 19 indicated that the slight differences in carbohydrate content among the 3 human forms of MPO could explain the enzyme multiplicity. For equine MPO, the authors could not exclude that differences in reactivity between the 2 forms also reflect subtle differences in heme content and amino acid composition near the reactive site.
The authors also observed one 86-kD band, which by comparison with human MPO 19, 22, 29 can be considered as the enzyme precursor but without enzymatic activity, perhaps because of the absence of a prosthetic heme group or because of an excess of glycosylation. This lack of activity could explain the lower A 430 /A 280 absorbance ratio obtained for equine MPO compared with human MPO. The difference in behavior between the human and equine precursors could reflect species differences in the maturation process of MPO.
After reduction with DTT, the 86-kD precursor band remained, but the bands corresponding to the native 120-kD enzyme disappeared to give 3 bands with molecular masses at approximately 76, 64, and 16 kD. By comparison with canine, 17 human, 1, 32 and bovine MPO, 6 the 76-kD band could be attributed to the hemienzyme 1 and the 64-and 16-kD bands, respectively, to the heavy and light subunits of the enzyme. A weakly stained band also appeared at 40 kD and could be attributed to the heavy subunit without a prosthetic group, as postulated by several authors. 30, 35 A sandwich ELISA for quantification of equine MPO in blood was developed following the classical sandwich ELISA method with 2 different polyclonal antibodies obtained against equine MPO. The sandwich complex (rabbit primary antibody-MPO-guinea pig secondary antibody) was recognized by a third antibody conjugated with alkaline phosphatase. The ELISA was appropriate for testing total MPO concentration in equine plasma, including native (active or inactive) enzyme, hemienzyme, and large and small subunits of the enzyme. The ELISA was for reliable quantification of equine MPO concentrations ranging from 0.78 to 50 ng/ml, with a linear reference curve for MPO concentrations between 3.12 and 25.00 ng/ ml on a logarithmic scale. The intraassay CV of the reference curve did not exceed 8%. The analytical sensitivity (0.50 ng/ml) allowed an easy measurement of MPO in plasma diluted 1:40. Flexible conditions for MPO incubation with the primary antibody were established: either at 4ЊC for 18 hours or at 37ЊC for 2 hours. No cross-reactions were observed with equine albumin and hemoglobin. The cross-reaction with other proteins from neutrophil granules such as elastase and cathepsins could not be tested because these proteins have not yet been purified from horses. However, the precipitation of these proteins during the dialysis step of polymorphonuclear neutrophil (PMN) extracts and the data from electrophoresis of purified equine MPO allowed the authors to infer the absence of contamination and cross-reaction in the ELISA with other neutrophil granule proteins. 11 For application to horse blood, the optimal sampling conditions were determined. The mean MPO concentrations measured in EDTA-and citrate-blood were similar and remained unchanged when the blood was centrifuged after a delay of 4 hours. The mean MPO value was higher in heparinized blood and increased with the centrifugation delay. The highest mean value was found in serum, in agreement with previous observations. 11, 33 The stimulation and degranulation of the neutrophils during blood coagulation explained the high MPO values in serum. However, Cooray et al. 7 used serum to assay bovine MPO but did not compare with plasma values. On the basis of previous results obtained by RIA by the authors, 11 it was decided to use EDTA-blood for all the others studies. When the use of EDTA was impossible (large blood volumes), citrate with a rapid centrifugation of the blood sample (within a maximal delay of 2 hours) was used to avoid an in vitro degranulation of the neutrophils.
Crude plasma may exhibit interference effects because of other biomolecules in the sample matrix. Other studies have shown that MPO binds to the plasma metalloprotein ceruloplasmin, 34 to anti-MPO immunoglobulins, 14 and to lipoproteins. 5 The local environment may also affect the binding between antibody and antigen; for example, interference effects are often suppressed if the sample is diluted. 25 In this study it was observed that plasma dilutions increased the sensitivity of the MPO ELISA, undoubtedly by reducing interactions between MPO and other biomolecules of the sample and by improving the binding between MPO and the primary antibody. The dilutions from 1: 20 to 1:60 were adequate for most of the samples, but the need of higher dilutions for some pathological samples could not be excluded. Under the conditions of this study, 1:40 or 1:60 dilution is a good compromise that allowed MPO concentration measurements in the linear part of the reference curve. In comparison, human samples have to be diluted from 1:30 to 1:100 according to the manufacturer's specification. g In horses with obstructive intestinal conditions, the MPO concentrations of blood samples drawn on arrival at the intensive care unit were always high, largely above the cutoff limit of 376 ng/ml. These findings agree with previous observations. 11, 15 High concentrations of MPO in blood from horses with obstructive intestinal conditions indicated an in vivo activation and a degranulation of the neutrophils in the systemic blood flow. Endotoxin absorbed from a damaged intestine can activate neutrophils 2, 8 or stimulate monocytes to release mediators stimulating neutrophils. Ischemia-reperfusion phenomena during successive torsion and detorsion of the intestine may also contribute to an exacerbation of cellular injury, resulting in excessive neutrophil accumulation and activation. 28 Using RIA determination of MPO, Grulke et al. 15 showed the important role played by neutrophil activation in the pathogenesis of acute abdominal disease and endotoxin shock and demonstrated the usefulness of MPO measurements as markers of neutrophil activation. The ELISA for equine MPO reported in this study, by its sensitivity and accuracy, offers a valuable tool to analyze MPO as a marker of neutrophil activation in horse intestinal disease conditions. Considering the potential usefulness of this ELISA for analyzing the involvement of MPO in various types of equine infections and inflammatory conditions, the assay is currently under validation with other biological fluids, such as peritoneal fluid, bronchoalveolar lavage fluid, and neutrophil suspensions. The ELISA could potentially also be used to study the in vitro modulation of the reactivity of neutrophils. Therefore, the results obtained with this new specific equine MPO ELISA may open new perspectives for the study, diagnosis, and follow-up of equine diseases associated with activated neutrophils. 
